Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

screen_shot_2012-10-05_at_09

Appointments and moves at the BIA

October 5, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, BioIndustry Association

The BioIndustry Association (BIA) has appointed Harren Jhoti and Will West to its Board of directors at its Annual General …
Appointment
114053815_tovey_341562c

GW Pharmaceuticals hires chief operating officer

October 4, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Chris Tovey, GW Pharmaceuticals

GW Pharmaceuticals has announced the appointment of Christopher John Tovey to the newly created position of chief operating officer. Tovey, …
Appointment
dame_christine_beasley_282x212

Non-executive directors of NHS Trust appointed

October 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christine Beasley, NHS, Sarah Harkness

Christine Beasley and Sarah Harkness have been confirmed as non-executive directors of the NHS Trust Development Authority.  Ms Beasley (pictured) …
Appointment
Bayer image

Bayer signs endometriosis pact

October 3, 2012 Research and Development, Sales and Marketing Bayer, Evotec, endometriosis

Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …
News
Roche and GSK image

Is it really safety first?

October 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Les Rose, Roche

The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …
Feature

Catalent and CTC Partner to Help Korean Pharma Take Their Products to Western Markets

October 2, 2012 Research and Development

Somerset, NJ, September 13, 2012 – Catalent Pharma Solutions and CTC Bio have entered into a collaboration to provide optimal …
News
Press release
votrient image

Survival boost for Votrient in mRCC

October 2, 2012 Research and Development, Sales and Marketing GSK, Nexavar, Pfizer, Sutent, Votrient

GlaxoSmithKline’s renal cell carcinoma drug Votrient has proved itself non-inferior to a bitter rival, Pfizer’s Sutent, in terms of progression-free …
News

Cmed Clinical Services Strengthens Management Team

October 1, 2012 Research and Development

HORSHAM, UK — September 13, 2012 – Cmed Clinical Services has today announced three new appointments to its management team …
News
Press release
yervoy image

BMS highlights Yervoy survival data

October 1, 2012 Research and Development, Sales and Marketing BMS, Roche, Yervoy, Zelboraf

Bristol-Myers Squibb’s melanoma drug Yervoy helps patients survive for longer than if they are receiving standard chemotherapy alone, according to …
News
paul_chew_medlo

Sanofi appoints Paul Chew as chief medical officer

October 1, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Paul Chew, Sanofi

Sanofi has appointed Dr Paul Chew as chief medical officer and head of global medical affairs. Taking up his post …
Appointment

FDA approves Bayer’s Stivarga

October 1, 2012 Research and Development, Sales and Marketing Bayer, FDA, KRAS, Roche, Stivarga, avastin

The FDA has approved Bayer HealthCare’s oncology pill Stivarga to treat patients with metastatic colorectal cancer (mCRC) whose disease has …
News
engelbert_tjeenk_willink_pv

Boehringer’s Engelbert Tjeenk Willink leaves firm

September 28, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, Engelbert Tjeenk Willink

Boehringer Board member Engelbert Tjeenk Willink, responsible for Marketing and Sales of Prescription Medicines, has decided to leave at the …
Appointment

Vertex abandons hep C drug

September 27, 2012 Research and Development, Sales and Marketing Alios BioPharma, Vertex, hep C

Vertex Pharmaceutical’s pipeline has been dealt a blow with the abandonment of an investigational hepatitis C compound. The US firm, …
News
andrew_witty_gsk

GlaxoSmithKline announces Board changes

September 27, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Witty

GlaxoSmithKline has announced several changes to its Board and Committee structure. The GSK Board of directors with effect from 1 …
Appointment
Roche image

Roche unveils New York research base

September 26, 2012 Research and Development New York, Nutley, Roche, translational research

Roche is to locate a new translational clinical research centre in central New York, as part of a shift towards …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026